Daily equity reports 22 oct 2018

1. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 22ND OCTOBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE ! INDIANEQUITYBENCHMARK:- The Sensex, on an intraday INDIAN MARKET 34315.63 basis, fell over 500 points, the Nifty fell below the key level of 10303.55 10,300.Investors and traders sold shares across sectors, barring ASIAN MARKET a few names and midcaps, too, fell sharply. GLOBALFACE CLOSE PREVIOUS NIKKEI 22532.08 ! 25561.40 AsianMarket- Asianmarketsfinishedmixedasofthemost recentclosingprices.TheShanghaiCompositegained2.58% andtheHangSengrose0.42%.TheNikkei225lost0.56%. 2167.51 SECTORIAL INDICES ! CLOSE CHANGE (%) U.S.Market-Dowendsmorethan300pointsloweronworries aboutglobalgrowth,interestrates. ! 10504.05 -1.36 Europeanmarkets- European markets are mixed. The FTSE 100 is -1.35 higher by 0.09%, while the CAC 40 is leading the DAX lower. They are -1.07 down 0.96% and 0.49% respectively. -1.38 25085.80 -0.41 CLOSE CHANGE (%) 4.00 2.59 VEDL 2.28 1198.00 1.87 TOP LOSERS CLOSE CHANGE (%) IBULHSGFIN 957 -6.57 -5.41 1100.30 -4.43 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE TREND STRATEGY SCRIPT CLOSE (%) 5.78 BEARISH 4.00 P R1 R2 10441 RESISTANCE R1-10440 R2-10570 R3 10572 BOSCH 10048 10179 10241 10310 10372 3.60 SUPPORT S1-10240 S2-10170 3.47 CLOSE (%) IBULHSGFIN 1894.70 -9.73 PEL 1427.20 -7.32 HCLTECH -6.16 TREND BULLISH NET (CR.) S3 S2 S1 24857 P R1 R2 R3 24170 24629 25088 25316 4680.64 SUPPORT S1-24850 S2-24620 RESISTANCE BANK NIFTY DII 3547.70 NSE TOTALS ADVANCE BANK NIFTY 5 6 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! Housingfinancestockscrackedamid! RBIextendsFY19-20giltstobridge fiscaldeficit As the 2019 general elections loom large, the PM Narendra Modi-led government is skidding towards meetingitsfiscaldeficittargetof3.3%oftheGDPthis fiscal.After announcing its decision to reduce market borrowingtargetforFY19,i.e.,borrowingRs70,000cr lessfromthemarketthanthebudgetedRs6.05lakhcr, concernswereraisedabouthowthegovernmentwill meet its target.The government, however, was confidentaboutfulfillingitstargetandisnowmaking efforts to meet the same. Thus, it has asked the country’sapexbanktheReserveBankofIndia(RBI)to convert two securities maturing in 2018-2019 and 2019-20havingatotalfacevalueofRs6,155crtotwo longer-tenorsecuritiesmaturingin2025-26and2023- 24,respectively.Thoughthegovernmentdoesnothave to worry about repaying these right away, recovery pressurewillprobablycontinuetohauntit,requiring the government to resort to this stunt in the future.Meanwhile, how will this affect the markets? Whenthegovernmentneedsmoney,itborrowsfromits banker, the RBI, which in turn, takes money from lenders such as banks, insurance companies, and mutualfunds. heavysellingpressure Marketswitnessedavolatile tradingsessionwithacross- the-boardsellingpressurewitnessedinallthemajorHFC nameswithIndiabullsHousingFinance,RepcoHome,Gruh Finance, HDFC Ltd tumbling 16.5%, 8.7%, 6.7%, & 4.2%, respectively.NiftyBank index relatively outperformed the Nifty index, but both indices shed 0.4% & 1.25%, respectively,attheclose.Themarketbreadthendedheavily in the favor of the declines with advance/decline ratio closingat2:5x. ! UltraTechCementdrops3%postQ2FY19 numbers Shares of UltraTech Cement were trading down 3% in afternoon session on Friday after its Q2FY19 numbers missedstreetexpectation.UltraTechCementhasreporteda weak set ofnumbersfor Q2FY19 on the operating front. Revenue in the quarter disappointed.Thecompanyhasreportedarevenuegrowth of 20% yoy to Rs8,151.5cr against an estimate of Rs7,936.4cr. was in-line but PAT ! LupingetsfiveobservationsingSpiriva pre-approvalinspection; Lupin has announced that its Pithampur Unit-3 (Indore) has recently been inspected by the USFDA and has received five observations.TheGMPinspectionwaspre-approvedinnaturefor Lupin’s Tiotropium DPI ANDA. This inspection was conducted between October 8-18, 2018. The company has said that these observationsareproceduralinnature.TiotropiumDPIissoldby Boehringer Ingelheim Pharmaceuticals under the brand Spiriva (inpowderform). Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

7. CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.